Cannabis Global Revenue Growth Rates (CBGL), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Cannabis Global Inc.  (CBGL)
 

CBGL's Revenue Growth by Quarter and Year

Cannabis Global's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CBGL Revenue (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
4th Quarter August -
3rd Quarter May 0.79
2nd Quarter February 0.63
1st Quarter November 0.57
FY 1.99





CBGL Revenue third quarter 2022 Y/Y Growth Comment
Cannabis Global Inc. reported decline in Revenue in the third quarter 2022 by -15.7% to $ 0.79 millions, from the same quarter in 2021.
The contraction in the third quarter 2022 Cannabis Global Inc.'s Revenue compares unfavorably to the Company's average Revenue doubling of 3878.98%.

Looking into third quarter 2022 results within Biotechnology & Pharmaceuticals industry 63 other companies have achieved higher Revenue growth. While Cannabis Global Inc.' s Revenue fall of -15.7% ranks overall at the positon no. 3980 in the third quarter 2022.


CBGL Revenue ( Y/Y Growth %) 2022
 2021 2020 2019
4th Quarter August - - - -
3rd Quarter May -15.7 % 4600 % - -
2nd Quarter February 2000 % - - -
1st Quarter November - - - -
FY   - 5233.33 % - -

Financial Statements
Cannabis Global's third quarter 2022 Revenue $ 0.79 millions CBGL's Income Statement
Cannabis Global's third quarter 2021 Revenue $ 0.94 millions Quarterly CBGL's Income Statement


CBGL Revenue (Quarter on Quarter Growth %)

 2022
 2021 2020 2019
4th Quarter August - -32.98 % - -
3rd Quarter May 25.78 % 3033.33 % - -
2nd Quarter February 10.53 % - - -
1st Quarter November -9.52 % - - -
FY (Year on Year)   - 5233.33 % - -


Back to CBGL Growth rate Comparisons >> Back to CBGL Growth rate Comparisons >>


Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #64
Healthcare Sector #582
Overall #3980

Revenue Y/Y Growth Statistics
High Average Low
12473.11 % 3878.98 % -54.71 %
(Nov 30 2021)   (Nov 30 2020)
Revenue third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #64
Healthcare Sector #582
Overall #3980
Revenue Y/Y Growth Statistics
High Average Low
12473.11 % 3878.98 % -54.71 %
(Nov 30 2021)   (Nov 30 2020)

Revenue by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Cannabis Global's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
3543.09 % 558.12 % -100 %
(May 31 2021)  


CBGL's III. Quarter Q/Q Revenue Comment
Cannabis Global Inc. achieved in the III. Quarter 2022 below company average Revenue jump of 25.78% quarter on quarter, to $ 0.79 millions.

Within Biotechnology & Pharmaceuticals industry 35 other companies have achieved higher Revenue quarter on quarter growth. While Cannabis Global's Revenue growth quarter on quarter, overall rank is 826.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #36
Healthcare Sector #176
Overall #826
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #36
Healthcare Sector #176
Overall #826
Revenue Q/Q Growth Statistics
High Average Low
3543.09 % 558.12 % -100 %
(May 31 2021)  


CBGL's III. Quarter Q/Q Revenue Comment
Cannabis Global Inc. achieved in the III. Quarter 2022 below company average Revenue jump of 25.78% quarter on quarter, to $ 0.79 millions.

Within Biotechnology & Pharmaceuticals industry 35 other companies have achieved higher Revenue quarter on quarter growth. While Cannabis Global's Revenue growth quarter on quarter, overall rank is 826.


Cannabis Global's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(May 31 2022)		 12 Months Ending
(Feb 28 2022)		 12 Months Ending
(Nov 30 2021)		 12 Months Ending
(Aug 31 2021)		 12 Months Ending
(May 31 2021)
Cumulative Revenue 12 Months Ending $ 2.62 $ 2.77 $ 2.17 $ 1.60 $ 0.97
Y / Y Revenue Growth (TTM) 170.59 % 5745.45 % - - -
Year on Year Revenue Growth Overall Ranking # 11 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) -5.35 % 27.77 % 35.29 % 65.38 % 1944.68 %
Seq. Revenue Growth (TTM) Overall Ranking # 22 # 6 # 5 # 0 # 0


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the May 31 2022 period, Cannabis Global's cumulative twelve months Revenue were $ 3 millions, company would post below average annual Revenue growth of 1944.68% year on year, if the fiscal year would end at May 31 2022.
A slow-down in the Cannabis Global's Revenue growth from the 0.63% growth in Feb 28 2022. Comparing the results with it's peers in Biotechnology & Pharmaceuticals industry, Cannabis Global's trailing twelve months Revenue growth, were the second highest.

Looking into Healthcare sector trailing twelve month Revenue increase, only one company had higher growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 11.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 2
Healthcare Sector # 2
Overall # 11

Revenue TTM Y/Y Growth Statistics
High Average Low
7377.35 %
 7377.35 %
7377.35 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 4
S&P 500 # 22
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the May 31 2022 period, Cannabis Global's cumulative twelve months Revenue were $ 3 millions, company would post below average annual Revenue growth of 7377.35% year on year, if the fiscal year would end at May 31 2022.
A slow-down in the Cannabis Global's Revenue growth from the 0.63% growth in Feb 28 2022. Comparing the results with it's peers in Biotechnology & Pharmaceuticals industry, Cannabis Global's trailing twelve months Revenue growth, were the second highest.

Looking into Healthcare sector trailing twelve month Revenue increase, only one company had higher growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 11.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 2
Healthcare Sector # 2
Overall # 11

Revenue TTM Y/Y Growth Statistics
High Average Low
7377.35 %
7377.35 %
7377.35 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 2
Sector # 4
S&P 500 # 22




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CBGL's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending May 31 2022 within Healthcare SectorY/Y Change %Revenue for the quarter ending May 31 2022
Cannabis Global Inc.-15.75%$ -15.746 millions
Camp4 Therapeutics Corporation-18.76%$ -18.761 millions
Lexaria Bioscience Corp -51.13%$ -51.132 millions


About Cannabis Global Revenue Growth Rates (CBGL), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Cannabis Global Inc (CIK 1413488).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001079973-22-000868
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Cannabis Global Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.